Abnormal Retinal Vessel Architecture in Albinism and Idiopathic Infantile Nystagmus.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
02 05 2022
Historique:
entrez: 26 5 2022
pubmed: 27 5 2022
medline: 31 5 2022
Statut: ppublish

Résumé

Infantile nystagmus syndrome (INS) causes altered visual development and can be associated with abnormal retinal structure, to which vascular development of the retina is closely related. Abnormal retinal vasculature has previously been noted in albinism but not idiopathic infantile nystagmus. We compared the number and diameter of retinal vessels in participants with albinism (PWA) and idiopathic infantile nystagmus (PWIIN) with controls. Fundus photography data from 24 PWA, 10 PWIIN, and 34 controls was analyzed using Automated Retinal Image Analyzer (ARIA) software on a field of analysis centered on the optic disc, the annulus of which extended between 4.2 mm and 8.4 mm in diameter. Compared with controls, the mean number of arterial branches was reduced by 24% in PWA (15.5 vs. 20.3, P < 0.001), and venous branches were reduced in both PWA (29%; 12.9 vs. 18.2, P < 0.001) and PWIIN (17%; 15.1 vs. 18.2, P = 0.024). PWA demonstrated 7% thinner "primary" (before branching) arteries (mean diameter: 75.39 µm vs. 80.88 µm, P = 0.043), and 13% thicker (after branching) "secondary" veins (66.72 µm vs. 59.01 µm in controls, P = 0.009). PWA and PWIIN demonstrated reduced retinal vessel counts and arterial diameters compared with controls. These changes in the superficial retinal vascular network may be secondary to underdevelopment of the neuronal network, which guides vascular development and is also known to be disrupted in INS.

Identifiants

pubmed: 35616929
pii: 2778863
doi: 10.1167/iovs.63.5.33
pmc: PMC9150830
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Subventions

Organisme : Medical Research Council
ID : MR/N004566/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J004189/1
Pays : United Kingdom

Références

J Ophthalmol. 2012;2012:460956
pubmed: 21904664
Eur J Neurosci. 2005 Oct;22(7):1825-9
pubmed: 16197526
Eye (Lond). 1998;12 ( Pt 3b):499-503
pubmed: 9775209
Ophthalmology. 2020 Apr;127(4):492-500
pubmed: 31937464
Hum Brain Mapp. 2019 Feb 15;40(3):777-788
pubmed: 30511784
Prog Retin Eye Res. 2012 Sep;31(5):377-406
pubmed: 22580107
Ophthalmology. 2011 Aug;118(8):1645-52
pubmed: 21570122
Prog Retin Eye Res. 2018 Mar;63:1-19
pubmed: 29129724
Sci Rep. 2016 May 27;6:26570
pubmed: 27231233
Lancet. 2015 Feb 26;385 Suppl 1:S14
pubmed: 26312836
Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1404-11
pubmed: 21071734
Dev Neurobiol. 2017 Jul;77(7):844-860
pubmed: 27907266
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4611-8
pubmed: 26200501
Biomed Res Int. 2014;2014:905472
pubmed: 25093188
Ophthalmology. 2011 Aug;118(8):1653-60
pubmed: 21529956
Pediatr Neonatol. 2014 Oct;55(5):341-51
pubmed: 25086850
J Neurosci Res. 2019 Jan;97(1):77-87
pubmed: 29761529
Mol Vis. 2009;15:45-59
pubmed: 19145251
Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1628-36
pubmed: 22323466
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):19
pubmed: 35029636
PLoS One. 2012;7(3):e32435
pubmed: 22427837
Ophthalmology. 2018 Dec;125(12):1953-1960
pubmed: 30098354
Invest Ophthalmol Vis Sci. 2011 Apr 08;52(5):2306-13
pubmed: 21220551
Brain Res Dev Brain Res. 1997 Mar 17;99(1):95-102
pubmed: 9088570
PLoS One. 2013;8(3):e57184
pubmed: 23526936
Semin Ophthalmol. 2021 Apr 03;36(3):110-114
pubmed: 33617401
Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2260
pubmed: 27124318
Sci Rep. 2017 Feb 10;7:42201
pubmed: 28186181
Cold Spring Harb Perspect Med. 2013 Jan 01;3(1):a006551
pubmed: 23024177
Neural Dev. 2014 May 18;9:11
pubmed: 24885435
Prog Retin Eye Res. 2018 Sep;66:49-84
pubmed: 29609042
PLoS Biol. 2008 Sep 30;6(9):e236
pubmed: 18828673
Hum Genet. 2021 Aug;140(8):1157-1168
pubmed: 33959807
Neuron. 2016 Jan 6;89(1):177-93
pubmed: 26711119
Br J Ophthalmol. 2006 Sep;90(9):1098-102
pubmed: 16707527
Hum Mol Genet. 2014 Aug 1;23(15):4086-93
pubmed: 24688117
Dev Dyn. 2006 Dec;235(12):3336-47
pubmed: 17061263

Auteurs

Shafak Toufeeq (S)

Oxford Eye Hospital, Level LG1 John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, United Kingdom.

Irene Gottlob (I)

Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University Of Leicester, University Road, Leicester, LE1 7RH, United Kingdom.

Zhanhan Tu (Z)

Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University Of Leicester, University Road, Leicester, LE1 7RH, United Kingdom.

Frank A Proudlock (FA)

Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University Of Leicester, University Road, Leicester, LE1 7RH, United Kingdom.

Anastasia Pilat (A)

Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University Of Leicester, University Road, Leicester, LE1 7RH, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH